• The global Non-Opioid Pain Relief Device market was valued at US$ 939.42 million in 2023 and is projected to reach US$ 1.56 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
• The global key manufacturers of Non-Opioid Pain Relief Device include Abbott Laboratories, Bayer AG, Bioelectronics Corporation, Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., NeuroMetrix Inc., Nuvectra Corporation and Omron Corporation, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
• We surveyed the Non-Opioid Pain Relief Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
